Skip to content
Agentic OS
Menu

Intelligence / Healthtech / New Clinical Trials / HALEON

Clinicaltrial registered2 Nov 2026

HALEON

2 Nov 2026: Trial registered · A Study Evaluating the Impact of a Painkiller Product on Quality-of-Life and Daily Functioning. Recorded in the ClinicalTrials.gov (US National Library of Medicine).

View the source record

Posted
2 Nov 2026
Title
A Study Evaluating the Impact of a Painkiller Product on Quality-of-Life and Daily Functioning
Conditions
Pain
Study Type
Observational
Status
Not Yet Recruiting
Countries
Singapore
Country
Singapore
Reference
NCT07909590
Location
Singapore
What this signal means

A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.

  1. United States leads with 192 of 777, then China (171).
  2. 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS

Find the decision makers at HALEON

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.

Start free

Across AOS Research

Other records for HALEON in our registers.

More from Singapore

New Clinical Trials

See all

Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.